Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer-Reference-Cited by-同舟云学术

Evaluation of novel highly specific antibodies to cancer testis antigen Centrin‐1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer

Published:2019-07-16 Issue:11 Volume:8 Page:5289-5300
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Jiao Rubin¹,Allen Kevin J. H.¹,Malo Mackenzie E.¹,Helal Muath¹,Jiang Zewei²,Smart Karishma²,Buhl Susan V.²,Rickles David³,Bryan Ruth A.²,Dadachova Ekaterina¹^ORCID

Affiliation:

1. College of Pharmacy and Nutrition University of Saskatchewan Saskatoon Saskatchewan Canada

2. Albert Einstein College of Medicine Bronx New York

3. RadImmune Therapeutics Tarrytown New York

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2379

Reference32 articles.

1. Cancer statistics, 2018

2. CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers

3. Germline deletion of Cetn1 causes infertility in male mice

4. Structure-function analysis of the EF-hand protein centrin-2 for its intracellular localization and nucleotide excision repair

5. Testis-Specific Murine Centrin, Cetn1: Genomic Characterization and Evidence for Retroposition of a Gene Encoding a Centrosome Protein

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bismuth chelation for targeted alpha therapy: Current state of the art;Nuclear Medicine and Biology;2022-11

2. Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside;Pharmaceutics;2021-04-21

3. Utility of 211At-Trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically Relevant Mouse Model;Journal of Nuclear Medicine;2021-02-05

4. Overcoming drug resistance in osteosarcoma and pancreatic adenocarcinoma with radioimmunotherapy;Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance;2021

5. Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature;Cancers;2020-02-19